Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Healius Limited (DE:PGZ)
FRANKFURT:PGZ
Healius Limited (PGZ) Stock Price & Analysis
1 Followers
PGZ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.66 - €1.76
Previous Close€0.86
Volume0.00
Average Volume (3M)N/A
Market Cap
€646.24M
Enterprise Value€1.70B
Total Cash (Recent Filing)AU$81.30M
Total Debt (Recent Filing)AU$1.78B
Price to Earnings (P/E)―
Beta0.72
Next Earnings
Aug 21, 2024EPS Estimate
<€0.01Last Dividend Ex-Date
Sep 07, 2022Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding726,099,943
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.96Price Target Upside11.63% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering7
Healius Limited News
PremiumCompany Announcements
Australian Retirement Trust Reduces Healius Stake
PremiumCompany Announcements
Perpetual Limited Ups Stake in Healius Limited
PremiumCompany Announcements
JPMorgan Ups Stake in Healius Limited
PremiumCompany Announcements
Healius Limited Announces Strategic Sale and New Chair
PremiumCompany Announcements
Healius Limited Director’s Shareholding Shift
PremiumCompany Announcements
Healius Ltd Director’s Shareholding Adjustment
PremiumCompany Announcements
Healius Director’s Shareholdings AdjustedPremiumCompany Announcements
Healius Limited Director’s Shareholding UnchangedPGZ FAQ
What was Healius Limited’s price range in the past 12 months?
Healius Limited lowest stock price was €0.66 and its highest was €1.76 in the past 12 months.
What is Healius Limited’s market cap?
Currently, no data Available
When is Healius Limited’s upcoming earnings report date?
Healius Limited’s upcoming earnings report date is Aug 21, 2024 which is in 47 days.
How were Healius Limited’s earnings last quarter?
Healius Limited released its earnings results on Feb 26, 2024. The company reported -€0.015 earnings per share for the quarter, missing the consensus estimate of -€0.012 by -€0.003.
Is Healius Limited overvalued?
According to Wall Street analysts Healius Limited’s price is currently Undervalued.
Does Healius Limited pay dividends?
Healius Limited pays a Notavailable dividend of €0.04 which represents an annual dividend yield of N/A. See more information on Healius Limited dividends here
What is Healius Limited’s EPS estimate?
Healius Limited’s EPS estimate is <€0.01.
How many shares outstanding does Healius Limited have?
Currently, no data Available
What happened to Healius Limited’s price movement after its last earnings report?
Healius Limited reported an EPS of -€0.015 in its last earnings report, missing expectations of -€0.012. Following the earnings report the stock price went down -7.317%.
Which hedge fund is a major shareholder of Healius Limited?
Currently, no hedge funds are holding shares in DE:PGZ
---
Healius Limited Stock Smart Score
Company Description
Healius Limited
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Medical Centres and Imaging. The Pathology segment provides pathology services. The Medical Centres segment provides services and facilities to general practitioners, specialists, dentists, IVF specialists and other healthcare professionals operating in the bulk billing and private billing sectors. The Imaging segment provides imaging and scanning services from stand-alone imaging sites, hospitals and from within the consolidated entity's medical centres. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leichhardt, Australia.
---
PGZ Stock 12 Month Forecast
Average Price Target
€0.96
▲(11.63% Upside)
Technical Analysis
Erlebnis Akademie AG
―
AURELIUS Equity Opportunities SE & Co. KGaA
―
Capitol Health Limited
―
Rhythm Biosciences Ltd.
―
Best Analysts Covering PGZ
1 Year
1 Year Success Rate
9/11 ratings generated profit
1 Year Average Return
+29.76%
reiterated a sell rating 10 days ago
Copying Steven Wheen's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +29.76% per trade.
---